List of Treatments for Prostate Cancer

Below is a listing of treatments and therapies for prostate cancer. Click on one to read more information or connect with others currently using it.

Nilandron (Nilutamide) for Prostate Cancer

Overview
Nilandron is approved by the U.S. Food and Drug Administration (FDA) for the treatment of metastatic (advanced) prostate cancer. It is prescribed for use in combination with surgical castration (removal of the…

Nubeqa (Darolutamide) for Prostate Cancer

Overview
Nubeqa is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult men with nonmetastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-sensitive prostate…

Orgovyx (Relugolix) for Prostate Cancer

Overview
Orgovyx is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced prostate cancer in adults. It is used as a form of androgen deprivation therapy (ADT) to reduce the levels of…

Pluvicto (Lutetium Lu 177 Vipivotide Tetraxetan) for Prostate Cancer

Overview
Pluvicto is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who…

Provenge (Sipuleucel-T) for Prostate Cancer

Overview
Provenge is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with metastatic castration-resistant prostate cancer (mCRPC) who have few or no symptoms. It is typically used in…

Rubraca (Rucaparib) for Prostate Cancer

Overview
Rubraca is approved by the U.S. Food and Drug Administration (FDA) for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adults who have a BRCA gene mutation (change) and who have…

Talzenna (Talazoparib) for Prostate Cancer

Overview
Talzenna is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with metastatic (advanced) castration-resistant prostate cancer (mCRPC) that carries mutations (variations) in genes…

Trelstar (Triptorelin Pamoate) Prostate Cancer

Overview
Trelstar is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced prostate cancer. It is used as part of androgen deprivation therapy (ADT) to lower testosterone levels, which…

Xtandi (Enzalutamide) for Prostate Cancer

Overview
Xtandi is approved by the U.S. Food and Drug Administration (FDA) to treat several forms of prostate cancer, including castration-resistant prostate cancer (CRPC), metastatic castration-sensitive prostate cancer…

Zoladex (Goserelin) for Prostate Cancer

Overview
Zoladex is approved by the U.S. Food and Drug Administration (FDA) for the management of prostate cancer. It is specifically indicated for use in combination with flutamide for individuals with locally confined…

Zytiga (Abiraterone Acetate) for Prostate Cancer

Overview
Zytiga is approved by the U.S. Food and Drug Administration (FDA) to treat prostate cancer. It is used in combination with prednisone to treat two types of advanced prostate cancer: metastatic (advanced)…

MyProstateCancerTeam is the social network for those living with prostate cancer. Get the emotional support you need from others like you, and gain practical advice and insights on managing treatment or therapies for prostate cancer. MyProstateCancerTeam is the only social network where you can truly connect, make real friendships, and share daily ups and downs in a judgement-free place.

MyProstateCancerTeam is not a medical referral site and does not recommend or endorse any particular provider or medical treatment. No information on MyProstateCancerTeam should be construed as medical and/or health advice.

Your Privacy is Our Priority

Connect with others who understand.